Bain Capital Private Equity to Acquire FIS – Fabbrica Italiana Sintetici
July 7, 2023
Bain Capital Private Equity has reached binding agreements to acquire the Ferrari family’s shareholding in FIS – Fabbrica Italiana Sintetici S.p.A. The purchase transfers ownership from Nine Trees Group (NTG) and the Ferrari Family to Bain Capital, positioning FIS to pursue further international growth and capacity expansion in API development and manufacturing.
- Buyers
- Bain Capital Private Equity
- Targets
- FIS – Fabbrica Italiana Sintetici S.p.A.
- Sellers
- Nine Trees Group S.p.A. (NTG), Ferrari Family
- Industry
- Pharmaceuticals
- Location
- Veneto, Italy
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Bain Capital and BC Partners Enter Joint Ownership of Fedrigoni
July 26, 2022
Packaging
Bain Capital Private Equity has signed definitive documents with BC Partners to establish joint ownership of Fedrigoni, the global producer of self-adhesive labels and fibre-based packaging products. The transaction combines a reinvestment by Bain with new investment from BC Partners to support Fedrigoni's M&A-led growth and sustainability agenda; the Fedrigoni family and management will remain invested and the deal is expected to close by the end of 2022 subject to regulatory approvals.
-
Bain Capital Acquires Controlling Stake in Engineering Group
February 5, 2020
IT Services
Bain Capital Private Equity signed a definitive agreement to acquire a controlling stake in the Engineering Group, the leading Italian IT services and digital transformation business, from funds advised by Apax Partners and Neuberger Berman. Neuberger Berman will reinvest alongside Bain Capital; the transaction remains subject to regulatory approvals. Engineering is headquartered in Rome and employs more than 11,000 professionals across multiple countries.
-
Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation
February 7, 2025
Pharmaceuticals
Bain Capital has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation (MTPC) in a carve-out from Mitsubishi Chemical Group Corporation for approximately 510 billion JPY (about $3.3 billion). The deal, led by Bain’s Private Equity teams in Asia and North America together with its Life Sciences group, will create an independent, standalone Japanese pharma platform focused on drug discovery and development across immunology, CNS, vaccines, diabetes and other priority areas; the transaction is expected to close in Q3 2025.
-
Bain Capital Special Situations Takes ~20% Stake in IMS Nanofabrication from Intel
June 21, 2023
Manufacturing
Bain Capital Special Situations agreed to acquire an approximately 20% minority stake in IMS Nanofabrication GmbH from Intel in a deal that values IMS at about $4.3 billion. The investment (expected to close in Q3 2023) will leave IMS operating as a standalone subsidiary led by CEO Dr. Elmar Platzgummer and is intended to accelerate the company's technology innovation and market expansion in multi-beam mask writing for advanced semiconductor nodes.
-
Bain Capital Acquires Controlling Stake in Somacis
August 7, 2024
Manufacturing
Bain Capital has agreed to acquire a controlling stake in Somacis, an Italian high‑technology printed circuit board (PCB) manufacturer, from Chequers Capital (which will reinvest alongside management). Somacis, founded in 1972 and employing more than 1,700 people across five production facilities in Europe, North America and Asia, serves high‑performance end markets including Aerospace & Defence, MedTech and Datacentres/AI; the deal is subject to regulatory approvals.
-
Bain Capital Private Equity Acquires Majority Stake in Mash Holdings
November 15, 2022
Retail
Bain Capital Private Equity agreed to acquire a majority stake in Tokyo-based Mash Holdings, the operator of fashion and lifestyle brands including gelato pique, SNIDEL and FRAY I.D. The firm said it will partner with Mash's management to strengthen the company's business foundation and accelerate medium- to long-term growth across its fashion, beauty and food brands.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.